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Abstract In traumatic brain injury (TBI), severe disrup-
tions occur in the choroid plexus (CP)–cerebrospinal ﬂuid
(CSF) nexus that destabilize the nearby hippocampal and
subventricular neurogenic regions. Following invasive and
non-invasive injuries to cortex, several adverse sequelae
harm the brain interior: (i) structural damage to CP epi-
thelium that opens the blood–CSF barrier (BCSFB) to
protein, (ii) altered CSF dynamics and intracranial pressure
(ICP), (iii) augmentation of leukocyte trafﬁc across CP into
the CSF–brain, (iv) reduction in CSF sink action and
clearance of debris from ventricles, and (v) less efﬁcient
provision of micronutritional and hormonal support for the
CNS. However, gradual post-TBI restitution of the injured
CP epithelium and ependyma, and CSF homeostatic
mechanisms, help to restore subventricular/subgranular
neurogenesis and the cognitive abilities diminished by
CNS damage. Recovery from TBI is faciltated by upreg-
ulated choroidal/ependymal growth factors and neurotro-
phins, and their secretion into ventricular CSF. There, by
an endocrine-like mechanism, CSF bulk ﬂow convects the
neuropeptides to target cells in injured cortex for aiding
repair processes; and to neurogenic niches for enhancing
conversion of stem cells to new neurons. In the recovery
from TBI and associated ischemia, the modulating neuro-
peptides include FGF2, EGF, VEGF, NGF, IGF, GDNF,
BDNF, and PACAP. Homeostatic correction of TBI-
induced neuropathology can be accelerated or ampliﬁed by
exogenously boosting the CSF concentration of these
growth factors and neurotrophins. Such intraventricular
supplementation via the CSF route promotes neural resto-
ration through enhanced neurogenesis, angiogenesis, and
neuroprotective effects. CSF translational research presents
opportunities that involve CP and ependymal manipula-
tions to expedite recovery from TBI.
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Introduction
Following physical damage to brain, a number of homeo-
static processes initiate recovery. Several regions and cell
typesinthecentralnervoussystem(CNS)aidintherepairof
traumatic brain injury (TBI). Control of astrocyte prolifera-
tion, microglia activation, and neuroinﬂammation is key to
restoring the integrity of blood–brain barrier (BBB) and
cerebralparenchyma(Cernaketal.2005;Lietal.2009).TBI
models have extensively focused on damage to brain capil-
laries and vasogenic edema. Systematic analyses of neural
injuries have delineated the breakdown and reactivity of the
BBB in TBI (Lenzlinger et al. 2001; Morganti-Kossmann
et al. 2007; Pun et al. 2009; Unterberg et al. 2004).
In contrast, few investigations have addressed TBI
phenomena at the other major transport interface: the
choroid plexus (CP) or blood–cerebrospinal ﬂuid barrier
(BCSFB) (Davson and Segal 1996). Subtle changes in
function of CP, a small but complex organ that dominates
CSF composition, can have wide-ranging effects on brain
(Emerich et al. 2005). CP is vulnerable to head injury, even
to the non-penetrating type of trauma (Kaur et al. 1996).
Third ventricle CP is sensitive to frontal blows, whereas the
lateral ventricle plexuses suffer from lateral hits to brain
(Maxwell et al. 1992). In view of the multitasking per-
formed by CP (Johanson et al. 2008; Redzic et al. 2005),
insight is needed on compensatory actions of CSF in
reconstituting injured cortex (Johanson et al. 2005a; Walter
et al. 1999). By providing trophic proteins to trauma sites
and supportive stem cell niches, the CP stabilizes the
physiologically perturbed brain.
This review analyzes several aspects of CP–CSF
involvement in TBI. First, the CP itself undergoes structural
distortion and functional changes even when the primary
physical insult has been inﬂicted on region(s) considerably
removed from the ventricular system (Ghabriel et al. 2010).
Time course of BCSFB recovery is important in re-estab-
lishing brain homeostasis. CP must metabolically stabilize
itself post-injury to retain regulatory capacities. Second, CP
epithelial cells are bioreactive in a homeostatic sense. That
is, in reaction to brain injury and ICP elevation, the epi-
thelium in BCSFB is sensitive to neurohormonal signals
that home in to CP epithelial cells (Chodobski and
Szmydynger-Chodobska 2001; Johanson et al. 2006).
Responding to stressful states, the CP epithelium releases
ﬂuid-regulatory neuropeptides into CSF (Johanson et al.
1999a; Shore et al. 2004; Yang et al. 2010). Third, immune
and inﬂammatory phenomena involving the CP are a sig-
niﬁcant part of post-TBI sequelae. These include increased
activity of epiplexus or Kolmer cells at the BCSFB
(Maxwell et al. 1992) and increased paracellular movement
of leukocytes into CSF (Szmydynger-Chodobska et al.
2009). Such immune phenomena in CP probably impart
mixed effects on brain recovery. Fourth, another factor
affecting recovery from central trauma and stroke is the
state of CSF bulk ﬂow or volume transmission (Johanson
et al. 2003). Nascent neurons and migrating neuroblasts,
that are important cellular elements in recovery processes
for TBI, depend on CSF orderly ﬂow which they follow
(Sawamoto et al. 2006). Moreover, continually ﬂowing CSF
provides sink action that facilitates removal of catabolites
and injury products from brain. When CSF ﬂow is curtailed
in CNS injuries or neurodegeneration, there is less efﬁcient
clearance of potentially toxic brain waste materials
(Silverberg et al. 2001). And ﬁnally, the CSF produced by
CP contains growth factors (Knuckey et al. 1996) and
neurotrophins that are conveyed to the injury locus (Walter
et al. 1999), and to neural stem cells in periventricular
regions (Schanzer et al. 2004). These peptidergic factors
likely promote healing at the injury locus and stimulate
neurogenesis for stabilizing cognitive processes.
The above mentioned ﬁve factors dealing with TBI in the
context of the CP–CSF-brain nexus (Johanson et al. 2010b)
constitute the topics of this review: (i) morphological
damage to CP, (ii) homeostatic response of CP to brain
ﬂuid/pressure imbalance, (iii) immune system interaction
with CP–CSF, (iv) sink action and debris clearance by CSF,
and (v) provision of growth factors and neurotrophins by CP
to brain for revitalization. These thematic points are
expanded following presentation below of: the baseline
physiology of CP–CSF (Johanson 2008; Spector 2010;
Wolburg and Paulus 2010), and the features of brain injury
models that reveal CP–CSF mechanisms of damage and
recovery (Chodobski et al. 2003; Ghabriel et al. 2010; Kaur
et al. 1996;P a l me ta l . 1995; Sharma and Johanson 2007b;
Sharma et al. 2010; Szmydynger-Chodobska et al. 2009).
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Elevated intracranial pressure (ICP) following TBI can be
life threatening. The rising ICP post-TBI is due to ﬂuid
retention in brain and CSF cavities. In several neurode-
generation models, including TBI, vasogenic edema at the
brain injury site and breakdown of the blood–CSF barrier
(BCSFB) in CP both contribute to ventriculomegaly and
edematous ﬂuid accumulation in CNS (Johanson et al.
2010a; Sharma et al. 2006, 2010). Fluid and pressure
buildup in brain may be exacerbated by debris (e.g. eryth-
rocytes) being transferred away from the injury site via bulk
ﬂow, and subsequently interfering with CSF reabsorption at
arachnoidal drainage sites. Therefore, the BBB, CP–CSF,
and arachnoid are all potentially signiﬁcant factors affecting
ICP and ﬂuid retention after trauma. Of these abovemen-
tioned items contributing to CNS destabilization post-TBI,
it is the CP of the BCSFB that is emphasized in this review.
Anatomically, the BCSFB resides within the ventricular
system in the form of CP tissues within the four ventricles.
Compartmentally, the relationship between BCSFB and
BBB is schematized in Fig. 1. CSF is the intervening
medium between CP and brain. Therefore, CP uses CSF as a
distribution medium to transfer anabolites into, and
catabolites out of, the cerebral parenchyma. The CP–CSF-
mediated supply and removal of substances is vital for fetal
brain development, adult maintenance, and the repair of
injured brain (including stimulated neurogenesis to sustain
cognition). Strategically located, the CP furnishes trophic
molecules to nearby neurogenic niches in the subventricular
zone (SVZ) and dentate gyrus (DG). CP–CSF thus serves as
a source (solute supply) and sink (solute removal) for brain.
Physical injury to brain leads to impairment of many
tasks performed by the BCSFB. Broadly speaking, three
major functions of CP epithelium are altered by TBI
sequelae: (a) the barrier role of choroid epithelial tight
junctions, (b) the dynamics of CSF production and ﬂow,
and (c) homeostatic activities involving molecular trans-
port (into and out of ventricles) to maintain the neuro-
chemical composition of brain ISF and CSF.
Impermeability of BCSFB
Cerebrospinal ﬂuid (CSF), like brain, is protected by a
barrier system. Situated in the epithelium of CP, the
BCSFB structurally consists of two components: the tight
junctions (zonulae occludentes) that weld neighboring
epithelial cells at their apical poles, and the basolateral
membrane that abuts the choroidal ISF (Smith et al. 2004).
Tight junctions in CP are slightly more permeable than
counterparts in BBB (Thomas and Segal 1998). Accord-
ingly, there is normally slow penetration of plasma proteins
into CSF at a rate inversely proportional to the square root
of the molecular weight of diffusing molecules. This cho-
roidal leakage of macromolecules is greater than at the
BBB. Still, the CP screens macromolecules to the extent
that the steady-state concentration of proteins in CSF is
only 0.01–0.001 that in plasma. Molecular sieving
(restricted diffusion) at the BCSFB occurs to hydrophilic
molecules as small as urea (mw 60). Such sieving of non-
electrolytes occurs at the basolateral membrane (Johanson
and Woodbury 1978). Together the tight junctions and
basolateral membrane impede diffusion of water-soluble
agents, small and large, from plasma to CSF.
Epithelial damage in ischemia, arterial hypertension,
hyperthermia, and TBI structurally disrupts the BCSFB,
allowing increased permeation of solutes across CP into
ventricular CSF (Murphy and Johanson 1985; Palm et al.
1995; Sharma and Johanson 2007a; Sharma et al. 2010).
These plasma-derived cytokines and peptides, once in CSF,
can eventually access the microenvironment of chemically
sensitive neurogenic regions under the ependymal wall.
Additionally, the CNS-inward movement of protein mac-
romolecules increases CSF osmotic pressure. Elevated
osmotic pressure in CSF draws systemic water into the
ventricles causing ventriculomegaly (Krishnamurthy et al.
2009).
Modulation of CSF production by CP
Most well known of the CP functions is CSF secretion.
Human CSF production is about 500 ml per day. Aceta-
zolamide (a carbonic anhydase inhibitor) and the cardiac
glycosides (Na–K-ATPase inhibitors) suppress CSF pro-
duction (Pollay et al. 1985), thereby reducing ICP. Several
neurotransmitters (norepinephrine, acetylcholine, seroto-
nin, and dopamine) and ﬂuid-regulating neuropeptides
Fig. 1 Anatomical relationships among the BCSFB, CSF, and BBB:
neurons receive supplies from two sources: the nearby cerebral
capillaries or BBB (mainly glucose, amino acids and free fatty acids)
and the more distant CP or BCSFB (mainly vitamins, growth factors,
neurotrophins, and hormones). Both the BBB and BCSFB reabsorb
neural waste products and unneeded proteins into blood. The brain
microvessel endothelium and CP epithelium both have tight junctions
that restrict diffusion of small water-soluble molecules: therefore ion
and organic solutes are actively transported via membrane carriers
(structural proteins) across the barriers. Ependyma is a single-cell
epithelial layer with highly permeable gap junctions that allows free
exchange of solutes paracellularly between brain ISF and ventricular
CSF
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123(arginine vasopressin, angiotensin II, atrial natriuretic
peptide, and basic ﬁbroblast growth factor) decrease CSF
formation rate (Johanson et al. 2008; Nilsson et al. 1992).
Enhanced sympathetic stimulation of CP from the superior
cervical ganglia, occurring in certain stresses/injuries to
CNS, reduces CSF output by CP (Lindvall et al. 1978).
Neuroendocrine modulation of CSF, particularly the
downregulated formation rate in hydrocephalus/:ICP,
involves participation of so-called ‘‘dark’’ epithelial cells in
CP (Weaver et al. 2004). Increasing frequency of neuro-
endocrine-like dark cells is usually associated with states
of reduced CSF formation (Johanson et al. 1999a, 1999b).
Therefore, CP dark cells become more common when CP
is exposed to agents that curtail CSF formation rate. Dark
cells also appear in high-pressure hydrocephalus (Shuman
and Bryan 1991) when CP epithelial cells shrink (become
more electron dense in micrographs) and the width of the
intercellular space expands. With TBI-induced decrease of
CSF production to protect brain against elevated ICP, one
expects to see morphological evidence of altered CP epi-
thelium as described above. Less ﬂuid formation by CP
leads to dwindling of CSF bulk ﬂow to the subarachnoid
space (SAS), a convective process that normally extrudes
injury products and excess proteins out of CNS (Pollay
2010).
Cerebrospinal ﬂuid (CSF) formation is evidently
decreased soon after TBI but, in later stages of the injury,
may undergo an increase. To prevent ICP from rising to a
dangerous level, it is therapeutically important to counter
the vasogenic edema buildup in brain by appropriately
curtailing CSF production, or by increasing water with-
drawal from brain (Harbaugh et al. 1979). Tracking the
changes in CSF dynamics and volume during reactive
phases of TBI injury is important since these factors crit-
ically set the ICP.
Homeostatic transporters in CSF-facing membrane
of CP
A little-appreciated function of CP epithelium is the active
array of reabsorptive transporters at the apical membrane.
Thesetransportersclearawaycatabolites,injury-breakdown
products (from the dismantling of erythrocytes leaking into
ventricles), and proteins/cytokines that penetrate CSF in
traumatized CNS. By actively removing organic solutes, the
transporters normally cleanse CSF of impurities. A key
question is whether these reabsorptive transporters, in con-
junction with lysosomal disposal of substrates taken up by
the epithelium, are overwhelmed inmassive injuries. Severe
disruption of CP epithelial cells and CSF in CNS disorders
greatly taxes the lysosomal/Golgi system (Johanson et al.
2010b). Extensive vacuole generation in CP epithelium
following TBI (Kaur et al. 1996; Palm et al. 1995) reﬂects
intense lysosomal activity that digests injury products
translocated at the BCSFB. Excessive vacuolation, induced
by xenobiotic agents, causes CP swelling. Swollen CP
exerts an impeding mass effect within the ventricles leading
to interrupted CSF ﬂow. Clearly, the coupled performance
of CP clearance transporters and lysosomal digestive sys-
tems in diseases (hydrocephalus) and disorders (TBI)
requires further examination in terms of CSF pathology and
therapeutics.
How CP transport failure can affect the CSF–brain
environment is seen in Kearns-Sayre syndrome (Spector
and Johanson 2010a), a genetic disorder. A regular supply
of ATP from mitochondria is needed to energize the active
transport systems. In the Kearns-Sayre disorder, the mito-
chondria do not provide sufﬁcient ATP to adequately drive
the active transporters in CP that remove organic anions
from CSF. Consequently the concentration of CSF homo-
vanillic acid, a brain catabolite needing elimination by the
Oatp transporter, is augmented due to less efﬁcient removal
of anion from the ventricles (Serrano et al. 2010). By
functional analogy, the dwindling ATP production in CP at
early stages of ischemia or TBI likely results in less
effective homeostatic transport at the BCSFB (Palm et al.
1995). This destabilizes CSF composition and delays brain
recovery.
When brain is injured, homeostatic transporters in CP
apical membrane are set into action in an attempt to restore
CSF composition by reabsorbing injury debris from the
ventricles. Extravasated proteins and peptide fragments
associated with TBI undergo diffusion and convection from
the injury site through cortical interstices to CSF for
excretion. Two primary CSF excretory mechanisms
operate: one is by bulk ﬂow (non-selective) clearance of
organic compounds along arachnoidal drainage sites, and
the other via active reabsorption by speciﬁc apical mem-
brane transporters in CP. The organic anion-transporting
polypeptide (Oatp) system plays a major role. CP apical
membrane transporters including Oatp, along with the
potentially toxic substances they reabsorb from CSF, have
been extensively documented (Ghersi-Egea et al. 2009;
Spector 2010; Zhang et al. 2010). In regard to reabsorption
from CSF of products generated by the breakdown of
erythrocytes and hemoglobin, the PEPT-2 transporter
clears the potentially toxic heme precursor, 5-aminolevu-
linic acid, from the ventricles (Hu et al. 2007). Disruption
of parenchyma in TBI releases Cl and K into extracellular
ﬂuid. Buffering of these ions is accomplished by transport
activities of the apically located Na–K–Cl cotransporter
and Na pump in CP that homeostatically regulate CSF Cl
and K concentrations (Keep et al. 1994; Parmelee et al.
1991). CSF and ISF ion concentrations signiﬁcantly affect
CNS excitability and therefore need to be exquisitely reg-
ulated by glia and barrier cells.
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A variety of techniques have been used to inﬂict mechanical
injury to brain. Several methodological approaches are
compiled in Table 1. They involve both invasive TBI (brain
stab and weight drop) as well as non-invasive TBI (move-
ment acceleration and blast wave). Analysis of damage was
performed on CP tissues and/or CSF at various stages or
sequelae of the pathophysiology development post-trauma.
Readers are referred to systematic reviews on TBI that
cover a wide spectrum of pathophysiology and means for
inducing neural trauma (Albert-Weissenberger and Siren
2010; Hicks et al. 2010; Thompson et al. 2005). This review
analyzes several experimental approaches revealing how
TBI affects the distributional nexus involving several con-
nected compartments (Fig. 2) in the CNS interior: CP, CSF,
ependyma, SVZ/neurogenic niches, and periventricular
brain tissue bordering CSF (Johanson et al. 2010b). In many
studies, the pathophysiological response to TBI was eval-
uated at several points from hours to weeks. Such time-
course analyses can track up- and down-regulation of
molecules involved in compensatory or restitution respon-
ses; and monitor the reversibility (or not) of structural
distortions.
One might think that the CP location, buried deep within
the CNS and suspended in shock-absorbing CSF, would
confer protection against a mechanical or physical impetus
delivered against the brain’s external surface. This is not
always the case. CP is sensitive to and injured by physical
perturbations created by blast waves or other TBI-induc-
tion procedures (Table 1). The diffuse injury model,
associated with sudden/intense lateral movement of the
head, creates shearing forces that tear choroidal vessels and
epithelium; the resulting hemorrhaging into the ventricles
provokes inﬂammation and can increase ICP (Maxwell
et al. 1992). Another non-invasive TBI approach exposes
experimental animals to a single blast meant to simulate
the military situation of soldiers exposed to nearby explo-
sions. Although a non-penetrating model of TBI, the blast
condition physically disrupts the epithelium of CP and its
intercellular spaces. This markedly affects BCSFB physi-
ology, including activation of phagocytotic systems such as
the epiplexus cells or macrophages that physically inter-
twine with CP apical membrane (Kaur et al. 1996).
Other TBI-induction procedures are partially or fully
invasive. Rats have been commonly used in TBI modeling
(Table 1). Weight drop is useful for reproducibly applying
a certain force to a circumscribed area on the cortical
surface. It is usually applied to one hemisphere. Thereby,
the contralateral intact hemisphere and lateral ventricle CP
can be used to control for the injured ipsilateral side. A
craniectomy exposes the dural membrane, upon which a
calibrated weight is dropped. Experimental parameters
vary considerably. Weights ranging from 25 to 450 g
are dropped on the dura from a height of 8 cm–2 m
(Chodobski et al. 2003; Ghabriel et al. 2010). Injury to CP
is severe enough to provoke an inﬂammatory response.
This involves leukocyte permeation of the inter-epithelial
paracellular pathway and recruitment/activation of epi-
plexus cells that afﬁx to the CSF-facing membrane.
Finally, the fully invasive approach to TBI induction
involves an incisive lesion or stab wound inﬂicted deep in
rat cortex (3–4 mm from dural surface). This penetrating
lesion does not directly, physically traumatize CP. Because
the lesioning cut or stab is made on one side of brain, it is
feasible to use the other cerebral hemisphere and lateral CP
as non-injured controls. Stab wounding is used to study
functional aspects of BCSFB (permeability) and the role of
CSF composition/bulk ﬂow in homeostatically mediating
recovery at injury loci (Sharma et al. 2010; Walter et al.
1999).
Pathophysiologic disruption of CP–CSF in TBI:
effects on CNS
Diverse homeostatic functions of CP normally beneﬁt the
brain in many ways. Therefore, it is important that BCSFB
damage brought about by TBI be stabilized quickly. Some
changes occurring in CP post-TBI are homeostatically
reactive, while others are pathologic or physiologically
disabling. Even as CP is repairing itself, it is also homeo-
statically responding to needs of the injured brain. Sorting
out these complex actions and reactions is challenging.
However, multiple time-course data generated from several
TBI models have been used to assess recovery of CP as
well as revitalization of brain injury. It is important to
consider acute adaptations (over days) versus longer
chronic adjustments (over weeks). Five aspects of CP–CSF
structure–function in TBI are now treated.
Morphological damage to BCSFB and permeability
alteration
Structural alterations often precede functional changes. It is
intriguing that external forces of the non-penetrating genre
(e.g., blast) physically disrupt CP epithelium situated far
from the brain surface receiving the explosion impact. In
ﬁndings reported below, all rats were active and appeared
physically normal after the blast. Following a single, non-
penetrativeblasttherewaswideningoftheintercellularcleft
betweenepithelialcells(Fig. 3)(Kauretal.1996).Thiscleft
response occurred as early as 1 day post-blast. A dilated
paracellularpathwayisnotafavorablesign.Itisreminiscent
of the enlarged intercellular spaces of CP in hydrocephalus,
a disease associated with shrunken choroidal epithelium and
TBI and choroid plexus–CSF 119
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123reduced formation of CSF (Weaver et al. 2004). As the
initial step in CSF formation, several ion transporters at
the basolateral membrane of CP (located at the edge of the
paracellular pathway) receive Na, Cl, and HCO3 from ISF
(Fig. 2, arrow #2) (Johanson et al. 2008). Normal CSF
formation depends upon the integrity of ﬂuid balance (vol-
ume and composition) between the epithelial cytoplasm and
ISF in the intercellular cleft. Cleft widening reﬂects altered
ion/water distribution; and it likely compromises CSF for-
mation efﬁciency.
Non-penetrative blasting, even a single episode,
severely distorts and ruptures the CP apical membrane.
One week after blasting, rat microvilli were dilated. And
cytoplasmic protusions with their inclusions exuded into
the ventricular lumen (Fig. 3). The apical microvillous
surface, having a great area for transport, contains
numerous ion and solute transporters that effect CSF for-
mation by extruding ﬂuid into the ventricles (Damkier et al.
2010). At the apical membrane are positioned many
organic solute transporters, such as LRP-1, PEPT-2, and
OATS (Angeletti et al. 1997; Smith et al. 2004; Spector
and Johanson 2010b). These apical transporters remove
excess anions/acids and peptides/fragments from CSF
(Fig. 2, arrow # 10). Reabsorption of potentially toxic
substances from CSF is important post-injury to remove
material that has leaked into ventricles across a compro-
mised BCSFB.
Choroid plexus (CP) epithelial heterogeneity is mani-
fested by differential response of various cells to the blast.
Electron microscopy reveals instances where one epithelial
cell is severely damaged but the adjacent neighbor is intact
(Fig. 4). This observation implies that certain cells in the
epithelial lining of BCSFB are more vulnerable than others
to stress. A similar phenomenon was found in a model of
acute transient forebrain ischemia (TFI), in which some
but not all CP epithelial cells were physically devastated
ISF CSF
CHOROID
PLEXUS
SVZ
EPENDYMA NEURONS 
AND ISF
BRAIN
CAPILLARY EPITHELIUM
VENTRICLE
VENTRICLE
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D
Fig. 2 Central role of CP–CSF in exchanging materials with brain:
ions, water, and organic molecules ﬁlter passively out of choroidal
capillaries (arrow #1) into interstitial ﬂuid (ISF). This is the ﬁrst step
in the material ﬂow by distributional nexus to the brain (green
arrows). Solutes diffuse through ISF up to basolateral membrane of
epithelium. Active mechanisms in membranes transfer solutes
sequentially across the basolateral (#2) and apical membranes (#3),
into ventricular CSF. As CSF ﬂows (#4) from ventricles to cisterna
magna, a small fraction of the CSF-borne substances diffuse across
ependyma (#5) into periventricular brain or are taken up by
specialized ependymal cells. Ependyma-penetrating substances dif-
fuse through brain ISF (#6) for transport into neurons (N); BBB, not
depicted, is interspersed among neurons. Material inﬂow to the CNS
interior thus sequentially involves CP, CSF, ependyma and brain. In
the opposite direction, there is a reverse nexus (red arrows) for
catabolites or injury products (as in TBI) released by neurons/glia into
brain ISF. Accordingly, cerebral catabolites such as homovanillic acid
diffuse through ISF (arrow #7), and down a transependymal
concentration gradient into CSF (#8). By bulk ﬂow of CSF (#9),
catabolites are convected to subarachnoid space (not depicted) or to
CP for active removal from the ventricles (#10), and then extrusion
transport across basolateral membrane (#11). Therefore, some
endogenous solutes or injury products end up being cleared passively
into blood of microvessels (#12) and venules draining CP. Overall
CSF is simultaneously a source (#1 to #6) and a sink (#7 to #12) for
distributing molecules, depending on prevailing concentration gradi-
ents between ventricular CSF and brain ISF. As such, the CSF and
bordering cells constitute a nexus for mediating trophic (CSF to brain)
and excretory (brain to CSF) ﬂuxes
Fig. 3 Dilated intercellular
spaces in choroid plexus after
blast injury: rat choroidal
epithelium 7 days post-blast
reveals dilated clefts or
intercellular spaces (IS). The
single blast condition is
described in text. Microvilli
(MV) are dilated. Ventricular
lumen contains pedunculated
cytoplasmic protrusions
released from
epithelium(asterisks). Basal
lamina is demarcated by
arrowheads. Scale bar is 2 lm.
Reprinted from Kaur et al. 1996
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123(Johanson et al. 2000). In the experimental TFI, a destroyed
epithelial cell was often ﬂanked by morphologically intact
neighboring epithelium (Palm et al. 1995). In the blast
studies by Kaur et al., there was epithelial restoration by
healing or replacement at 2 week. Remarkably in the TFI
experiments, the choroid epithelial cells were largely
recovered (or replaced?) 24 h after the ischemia insult
(10 min of carotid occlusion and hypotension) and reper-
fusion (Palm et al. 1995). The ability of severely damaged
CP epithelium to recover relatively rapidly from both
physical and neurochemical disturbances intimates a fun-
damental role of BCSFB in servicing the brain.
For the BCSFB to maintain a barrier function of
screening plasma macromolecules from entering CSF, it is
essential that tight junctions and external plasma mem-
branes (basolateral and apical) be intact. Breaching of
BCSFB is expected when structural components of the
epithelium are grossly distorted, as in traumatic injury to
brain. Sharma and colleagues have quantiﬁed BCSFB
permeability in rat TBI caused by stabbing parietal cortex
(Fig. 5). Radioactive iodine, administered systemically and
allowed to distribute for 5 min, was assayed in CSF at 5 h
post-TBI induction. Greater uptake of tracer iodine by CSF
of injured rats, versus intact controls, pointed to a more
permeable BCSFB. This functional outcome was consistent
with morphological damage to CP caused by TBI (Fig. 6).
Opening of BCSFB in TBI, with consequent inﬂux of
plasma proteins/cytokines into CSF, places the ventricles
and periventricular brain regions at risk for edema and
other disability (Fig. 7). Ventriculomegaly, observed in
TBI and hyperthermia, is adversely caused in part by
Fig. 4 Neighboring epithelial cells in choroid plexus with and
without damage: electron micrograph shows adjacent epithelium in
rat CP 14 days after a single blast injury. Cell on left has a great
number of hydropic vacuoles, likely reﬂecting enhanced activity of
lysosomes (Johanson et al. 2010b) processing/digesting debris
generated from injury. Microvilli in injured cell are more dilated
than counterparts in the relatively intact epithelial cell on right. Basal
lamina is indicated by arrows. Tight junctions are encircled. Scale bar
is 1.5 lm. Reprinted from Kaur et al. 1996
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Fig. 5 Enhanced permeability of BCSFB after TBI in adult rat:
Breakdown of CP epithelial barrier was evaluated by rapid uptake
(over 5 min) of radioiodine in plasma into CSF (sampled from
cisterna magna). At 5 h of TBI, the permeability to
131I increased
signiﬁcantly by 7-fold, compared to non-lesioned controls (P\0.01,
ANOVA followed by Dunnet’s test). Bars are means ? SD for
5 animals. Permeability change was blunted if Cerebrolysin (CERE),
a mixture of growth factors and trophic peptides, was administered
1h( P\0.05) but not at 2 h post-induction of stab wound to parietal
cortex (see Table 1). CONT control (sham surgery, no lesioning)
Fig. 6 TBI damage to CP: micrograph shows damage to CP in the
right lateral ventricle 5 h after stab injury to the ipsilateral cerebral
cortex (parietal) in the rat. The choroidal epithelium appears
shrunken. Disruption to the epithelial cells manifests as the uptake
of serum albumin (brown reaction product). This indicates damage to
the normally restrictive BCSFB (Johanson and Sharma, unpublished
observation)
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123protein buildup in CSF when CP fails to restrict diffusion
of plasma-derived macromolecules (Sharma et al. 2006).
Homeostatic response of CP to brain ﬂuid/pressure
imbalance
A consistent feature of severe TBI is ﬂuid retention by the
brain–CSF nexus. Consequently, ICP escalates. Passive
and active physiologic mechanisms counter the intracranial
hypertension. Passively, the rising pressure in CSF exerts
an opposing force on blood ﬂow to CP. Reduced perfusion
of the plexus eventually lowers substrate availability to the
epithelium for ﬂuid production. On the active side of
compensation, ﬂuid-regulating peptides are released into
CSF to downregulate ﬂuid turnover into ventricles. Atrial
natriuretic peptide (ANP) concentration in human CSF
increases in proportion to augmented ICP (Yamasaki et al.
1997). In an animal model, exogenous ANP presented
intraventricularly curtails CSF formation (Steardo and
Nathanson 1987) and reduces ICP. ANP increases the
number of neuroendocrine-like dark epithelial cells in CP
(Preston et al. 2003). This is usually a state associated with
diminished CSF production (Weaver et al. 2004). Conse-
quently, as an inhibitory modulator of CSF formation, ANP
is regarded putatively as a regulator of ICP (Johanson et al.
2006).
Dark epithelial cells appear in CP, in vitro and in vivo,
following administration of ANP, arginine vasopressin
(AVP), and basic ﬁbroblast growth factor; all of these
peptides inhibit CSF formation (Johanson 2008). Dark cells
in CP also become more numerous in high-pressure
hydrocephalus (Shuman and Bryan 1991), a condition in
which epithelial deformation is accompanied by expanded
intercellular clefts (Weaver et al. 2004). As noted above,
some TBI models also display widening of intercellular
clefts. A related question: Is there an increased number of
CP dark cells in TBI? Yes, electron dense, dark cytoplasm
occurs in many epithelial cells in experimental TBI
(Ghabriel et al. 2010); whether these dark cells reﬂect
pathology or a compensatory response awaits resolution.
Systematic TBI studies in the future should inform on how
ICP changes correlate with CSF titers of ANP and CP
epithelial dark cells. Assessing the CP’s role in regulating
ICP, during acute versus chronic stages of TBI, would
expedite models for brain ﬂuid dyshomeostasis and its
correction.
Immune system interaction with CP–CSF and brain
Immune cell access to CP and CSF substantially increases
during recovery phases of TBI. Phagocytosis of dismantled
structural elements and extracellular debris in injured CP is
essential for restoring BCSFB functional integrity. Hem-
orrhaging associated with brain trauma brings erythrocytes
and other blood cells into the CP interstitium, dilated
paracellular pathways, and ventricular CSF. Within hours
of head acceleration injury in a non-human primate,
monocytes are observed in the intercellular clefts of CP
(Maxwell et al. 1992). Some peripheral monocytes and
other leukocytes that gain access to ISF (Fig. 2, arrow #1)
and the impaired epithelium evidently differentiate into
macrophages such as epiplexus (Kolmer) cells. Even a
week after head acceleration, there was transepithelial
migration of monocytes/macrophages into CSF where they
evidently differentiated into active Kolmer cells (Maxwell
et al. 1992). Similarly, after a cerebral penetrant lesion, the
epiplexus cells or intraventricular macrophages became
activated by 6 h. Activation was characterized by conver-
sion from a smooth to rufﬂed appearance, and by loss of
ﬁlopodia concurrent with a morphing into a spherical body
(Maxwell and McGadey 1988).
Fig. 7 TBI damage to ependyma/periventricular regions: Image
shows damage to periventricular ependymal cells in the third
ventricle and the surrounding neuropil 5 h after TBI in the right
parietal cortex of the rat. Uptake of albumin marker (from plasma) is
seen as the brown reaction product visible in the ependymal lining.
Also vacuolation, edema, and sponginess around the periventricular
neuropil are apparent. In the neuropil, the albumin-labeled neurons
reﬂect widespread disruption of the BBB (and indirectly, the BCSFB)
after TBI to cerebral cortex (Johanson and Sharma, unpublished
observation)
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123From the CSF side of CP, the Kolmer cells afﬁx their
processes and bind intricately to the apical membrane
glycocalyx. Well known for phagocytosing ability, the
Kolmer cells also have antigen-presenting capabilities.
They monitor immune status of CSF and presumably effect
adjustments to rid CSF of contaminating plasma proteins
and cytokines. Epiplexus cells increase in both number and
activation state in response to the broken-down BCSFB in
TBI. Kolmer macrophages remain active until CSF is
cleansed of contaminating plasma and erythrocyte ele-
ments. When residual blood has been cleared from the
ventricles (at 1 month post-injury in the head acceleration
model, and by 2 week in the cerebral penetrant model), the
Kolmer cells become deactivated (Maxwell et al. 1992;
Maxwell and McGadey 1988). In the non-penetrative blast
model, the epiplexus cells remained activated (enhanced
immunostaining with monoclonal antibodies OX-42, OX-
18, and OX-6) until 3–4 weeks after injury induction at
which time CP epithelium regained normal ultrastructure
(Kaur et al. 1996). Collectively, the information indicates
that 2–4 weeks are needed by the CP-attached Kolmer cells
to completely remove residual blood elements from CSF
after TBI induction.
Increased trafﬁcking of leukocytes across CP in TBI
also impacts brain wound healing. Neutrophils penetrated
choroidal blood vessels (Fig. 2, arrow #1) 4 to 48 h after
brain trauma (Carlos et al. 1997). Within 4 h of injury by
weight drop to rat cortex there was increased penetration of
neutrophils across BCSFB into CSF, apparently facilitated
by the ipsilateral CP (Chodobski et al. 2003). Migrating
neutrophils were probably carried by CSF bulk ﬂow from
the lateral ventricle to SAS overlying the fronto-parietal
cortex. There, the neutrophils secreted vascular endothelial
growth factor (VEGF) into extracellular matrix at the
wound locus for gradual release from heparin sulfate pro-
teoglycan binding sites during healing. Unfortunately,
VEGF delivered via CP–CSF to injured cortex exacerbates
edema in TBI via enhanced angiogenesis and microvessel
permeability. In the relapse phase of another disorder,
multiple sclerosis (MS), there is increased migration of
leukocytes through CP to CSF. This CSF penetration is
followed by convective distribution of the leukocytes to
periventricular and perivascular sites of the MS lesion.
Therapeutically, there is the need to exert ﬁner control of
neutrophil migration across BCSFB in certain diseases as
well as trauma.
Sink action and clearance of CSF injury products
Consequent to TBI, the central extracellular ﬂuid becomes
contaminated with blood cells, cytokines, and cellular
breakdown products. Macrophages, particularly the epi-
plexuscellsthatarephysicallyentangledwithCPepithelium,
primarily digest erythrocytes that have extravasated into
CNS. Due to potential toxic effects of organic acids, excess
proteins and peptide fragments created by neuronal disinte-
gration, there is urgency for eliminating toxious waste
products. Long appreciated for its great ability as a reab-
sorbing organ, the CPwas onceregarded asbeing primarily a
tissue for clearing noxious waste substances from CSF (Case
1959). Current thinking recognizes that the plexus performs
multiple functions in addition to its extensive reabsorptive
capabilities (Johanson et al. 2008).
Following uptake from CSF (Fig. 2, arrow #10), harm-
ful molecules are disposed in part by enzymatic breakdown
within CP epithelium. This is manifested by an abundance
of vesicles, inclusion bodies, and lysosomes (Johanson
et al. 2010b). Another component of disposal involves
transporters at the plasma-facing membrane. There, the
basolateral exporters Mrp-1, Mrp-4, Oatp2, and Ent1
(Spector and Johanson 2010b) translocate solutes from
cytoplasm into choroidal interstitium (Fig. 2, arrow #11).
From ISF, substances that are being cleared out of CNS
diffuse into venous blood for systemic elimination (Fig. 2,
arrow #12).
Before waste solutes are acted upon by CP lysosomal
breakdown or basolateral transporter extrusion, they ﬁrst
must be taken up from CSF (Fig. 2, arrow #10). Because
CNS lacks true lymphatic vessels, many catabolites and
proteinaceous materials are necessarily reabsorbed by
active transporters at the BCSFB and BBB. In concert with
active reabsorptive transporters at the abluminal (ISF-fac-
ing) membrane of cerebral capillaries, the CP apical
membrane–CSF interface has a major work role in elimi-
nating toxicants from CSF. An array of solute transporters
at the CP apical membrane, including Oatp-D, Oatp3, Pgt,
LTC4, and Cnt3 (Spector and Johanson 2010b), actively
removes organic anions, peptide fragments, prostaglandins,
leukotrienes, and nucleosides that diffuse transependy-
mally into the ventricles from brain. Upon reaching large-
cavity CSF, the waste or superﬂuous products are cleared
actively by CP. Additional clearance takes place by CSF
bulk ﬂow via arachnoidal drainage into lymph and venous
blood (Grzybowski et al. 2006; Johnston et al. 2004; Pollay
2010). The nature, selectivity, afﬁnity, and capacity of
efﬂux/reabsorptive transporters at the BCSFB have been
delineated (Spector 2010; Spector and Johanson 2010b). In
TBI, quick removal of residual blood in CSF by phago-
cytosis is essential for restoring efﬁcient reabsorption by
organic solute transporters in CP.
By convecting molecules of all sizes (and even residual
erythrocytes), the CSF bulk ﬂow through the ventriculo-
subarachnoid spaces acts like a quasi-lymphatic excretory
system. Indeed, a considerable volume of CSF drains
through nasal mucosa into cervical lymphatic glands
(Johnston et al. 2004; Szentistvanyi et al. 1984). By exerting
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123sink action on brain extracellular molecules, the ﬂowing
CSF in transit to drainage sites gathers excess water, protein
debris, and organic catabolites (Hochwald et al. 1976;
Parandoosh and Johanson 1982). Effective sink action
depends on continual CSF formation and drainage to
maintain the appropriate transependymal concentration
gradients that promote net diffusion of molecules into the
ventricles (Fig. 2, arrow #8). Consequently, if CSF forma-
tion by injured CP is curtailed early in the TBI patho-
physiologic cascade, then the CSF clearance of waste
products would be less efﬁcient.
Optimal CSF secretion depends upon adequate CP blood
ﬂow, a clean interstitium free of excessive immune cells
and hemorrhage products, a patent paracellular pathway
and restrictive tight junctions, and efﬁcient epithelial
transport supported by adequate ATP availability (Spector
and Johanson 2010a). Therefore, in early stages of TBI
when CP structure and function are debilitated, and sym-
pathetic tone to the epithelium may be increased as part of
the stress response, one expects less CSF ﬂow into and
through the ventricles (Lindvall et al. 1978). Decreased
CSF formation in the initial phase of TBI ﬁts the obser-
vation of an increased number of dark epithelial cells and
widened intercellular clefts (Ghabriel et al. 2010). As
recovery from TBI proceeds, however, by 3–4 weeks the
BCFSB/epithelial integrity is restored. Re-establishment of
CSF formation would restore CSF sink action, assuming
that arachnoidal drainage routes are patent. At later stages
of TBI, however, the CSF and brain ﬂuids may still be
imbalanced as manifested by ICP instability. Additional
ICP data for TBI models at various stages will provide a
clearer picture of relations between CP and CSF pathology
and CSF dynamics throughout recovery.
Provision of growth factors and neurotrophins
by CP to brain
As prelude to discussing the role of CSF-delivered peptides
in repairing TBI, we now address various levels (or sour-
ces) of peptidergic support for homeostatically restoring
the injury site. Level one is the primary compensatory
(reactive) expression of neurotrophic and regenerative
factors by parenchymal/vascular cells in and around the
wound. This is exempliﬁed by a 5-fold increase in nerve
growth factor (NGF) mRNA in cortex 1 day after TBI in a
controlled-contusion model (DeKosky et al. 1994). Also,
transcripts for neuropeptides IGF-1 and cholecystokinin are
upregulated up to 10-fold in cerebral cortex adjacent to
injury 1–3 day post-contusion (Sandberg Nordqvist et al.
1996). The second level is represented by peptides puta-
tively secreted from CP, in homeostatic response to TBI,
and distributed via CSF to the traumatized region (Chiaretti
et al. 2008; Walter et al. 1999). This is endogenous
boosting of brain repair processes by neuroendocrine
conveyance of CP-derived peptides over a considerable
distance by volume transmission (rather than via local
autocrine/paracrine processes). If CP-BCSFB function is
severely compromised, however, as in early-stage TBI,
additional extrinsic support enhances neuroregenerative
capacity of traumatized brain. Accordingly, level three, the
one emphasized in this review section, deals with exoge-
nous or pharmacologic augmentation of CSF peptide lev-
els. Although performed in animals by intraventricular
delivery of test agent, the experimental information gen-
erated for accelerated recovery may be useful for strate-
gizing translational therapy of human TBI. The discussion
below and the compilation in Table 2 treat levels 2 and 3,
emphasizing the latter.
Peptide secretions by CP into CSF (Fig. 2, arrow #3)
promote recovery from TBI and other neurodegeneration.
A plethora of growth factors and neurotrophic proteins
synthesized by CP epithelium is released into CSF
(Chodobski and Szmydynger-Chodobska 2001; Johanson
et al. 2000). These peptidergic agents then ﬂow (Fig. 2,
arrow #4) to a myriad of parenchymal targets in brain
(arrow #6). A popular pharmacologic approach ampliﬁes
the endogenous level of a CSF peptide by injecting/infus-
ing the test agent into a lateral ventricle. This is done to
evaluate hypothesized neuroregenerative and neuroprotec-
tive actions (Johanson et al. 1999b). CSF bulk ﬂow carries
growth factors and neurotrophins from CP to nearby neu-
rogenic niches (SVZ and DG), and to more distant regions
such as fronto-parietal cortex injured by trauma. This
neuroendocrine function of CSF (Kozlowski 1986; Scott
et al. 1977) involves convection-delivered peptides to
modulate neurogenesis and facilitate healing. Ischemia has
been widely studied in this context (Johanson et al. 2003),
but TBI has received less attention for CSF pharmacologic
manipulation. TFI and TBI have common pathogenetic
mechanisms. Ischemia ﬁndings for CSF growth factor- and
neurotrophin-promoted neurogenesis enhance this discus-
sion (Kernie and Parent 2010; Matsuoka et al. 2003;T u r -
eyen et al. 2005) because post-traumatic cerebral ischemia
is reputedly the ﬁrst cause of neuronal death after head
injury (Chiaretti et al. 2008).
Prior to pursuing therapies for disease/injury modiﬁca-
tion, it helps to gain insight on natural homeostatic
mechanisms that aid injured brain. Expression of trophic
factor transcripts in lateral ventricle CP is sensitive to CNS
injuries. Responding to forebrain ischemia, the CP epi-
thelium upregulates TGFb isoforms (Knuckey et al. 1996);
and in reaction to cortical trauma, the plexus increases
secretion of IGF-II and IGFBP-2 into CSF (Walter et al.
1999). In rat TBI, IGF-II is conveyed via CSF from CP to
cortical injury sites (Fig. 2, arrows #3-6) where the hor-
mone presumably stabilizes parenchyma and interstitium.
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123Such endogenous IGF-II boosting happens relatively early
after injury and thus appears to be a rapid response to
neural trauma. A key question is how CP, not directly
traumatized, receives information from a remote brain
injury site to appropriately adjust its expression/secretion
of certain peptides to mediate homeostasis. Deserving
elucidation is whether injury signals (cytokines?) travel
from injury site to CP via ISF–CSF routes (Fig. 2, arrows
7–9), neurogenically, or by a vascular pathway (arrow 1).
Such information would advance modeling for homeostatic
peptide feedback loops: from injured brain to CP–CSF
(afferent limb) and then back to the injury site (efferent).
In addition to analyzing exogenous or pharmacologic
peptide modulation of injury loci, it is relevant to determine
effects of the same test agent on neurogenic niches (Fig. 2,
arrow #5). This is salient because stem cell regions stimu-
lated by peptides spawn newly birthed neurons for migra-
tion to injury sites. There, remodeling supposedly replaces
dying or dead cells with new neurons for incorporation into
circuits. Neurogenesis targets for endogenous choroidal
secretions [or for exogenous peptide administered intra-
ventricularly (arrow #4)] are the SVZ (arrow #5) near the
ependymal wall in the lateral ventricle and the subgranular
region (SGR) of the dentate gyrus–hippocampus. In
embryonic-fetal development and for adult neurogenic
maintenance, the niche stem cells require extrinsic modu-
lation from factors distributed by CP–CSF (Miyan et al.
2003; Owen-Lynch et al. 2003). Studies of neurodegener-
ation, including TBI and stroke, provide substantial evi-
dence that growth factors and neurotrophins given
exogenously to CSF (i.c.v. by osmotic pump) strengthen the
niches and stimulate neurogenesis. Enhanced generation of
new neurons secondary to CSF peptide supplementation,
under many conditions, reduces cognitive deﬁcits created
by TBI. Pharmacologically exploiting the CP–CSF–epen-
dyma/SVZ distributional nexus (Fig. 2, arrows #1-5) may
offer therapeutic opportunities to remediate cognition losses
sustained in brain injury (Johanson et al. 2005b).
Level 3 studies addressing TBI, in the context of neu-
rogenic peptides delivered from the CSF side of the neu-
rogenic niches, are overviewed in Table 2. Several
peptides, when exogenously boosted in CSF, are neurore-
generative and help to restore cognition post-TBI. CSF-
administered S100B, FGF2, and NGF all raise or restore
neurogenic capacity diminished in TBI (Table 2). Typical
experimentation has involved osmotic pump infusion of the
test peptide for several days. BrdU was injected at varying
time points prior to sacriﬁce to monitor proliferation
(dividing cells) and nascent neuron survival. Intraventric-
ular infusion of peptide was followed by cognition testing,
usually by behavior assessment in the Morris water maze.
Post-mortem analyses of hippocampus included immuno-
staining with markers for stem cells, glia, and neurons.
Neurogenic and neuroprotective effects of several peptides
in CSF are now discussed below.
S100B is a peptide marker that increases in CSF after
TBI. As a peptide released from injured astrocytes, S100B
in CSF reﬂects trauma sequelae in brain. S100B has also
been tested for neurogenic ability. Intraventricularly
infused S100B stimulates neurogenesis and improves spa-
tial memory in rats traumatized by ﬂuid percussion
(Table 2). Simultaneous occurrence of increased neuro-
genesis and improved cognition led to the hypothesis that
the two phenomena are linked (Kleindienst et al. 2005).
Additional support for this working model, i.e., CSF drug-
induced neuroregeneration, has been provided in compa-
rable studies testing other neuropeptides (Table 2).
Basic ﬁbroblast growth factor (FGF2) has mitogenic and
neurogenic properties (Kernie and Parent 2010; Mudo et al.
2009; Tureyen et al. 2005). When instilled i.c.v into rats
impaired by ﬂuid percussion injury, the exogenous FGF2 in
CSF increased cell proliferation in the SVZ and DG (Sun
et al. 2009). Cognition reduced by TBI was also improved
by FGF2 infusion into a lateral ventricle (Table 2). FGF2
levels in periventricular regions are also elevated by
intraventricular infusion of adenovirus that mediates gene
transfer of FGF2. This transgenetic manipulation efﬁ-
ciently elevated the FGF2 in CSF and ampliﬁed the number
of BrdU-positive cells in gerbil SVZ (Matsuoka et al.
2003). That CSF delivery of peptide can provide effective
TBI therapy is encouraged by promising ﬁndings on
intranasally delivered FGF2. Thus, following ischemia
induction in rats, the nasal delivery of FGF2 augmented
progenitor cell number in SVZ and DG; and improved
behavioral performance as judged by modiﬁed Neurologi-
cal Severity Scores (Wang et al. 2008). Intranasal admin-
istration of peptides circumvents the BBB, allowing
efﬁcient access to CSF and thus neurogenic regions bor-
dering the ventricles (Reger et al. 2008).
Vascular endothelial growth factor (VEGF) instilled
intraventricularly holds promise in promoting neurogen-
esis/angiogenesis and reversing untoward effects of TBI. In
both mice and rats, the osmotic pump infusion of VEGF
into a lateral ventricle promoted hippocampal and SVZ
neurogenesis beneﬁcial for recovery from TBI. In vitro
experimentation demonstrated that VEGF directly modu-
lates clonally derived adult rat neural stem cells, which
themselves express VEGF and VEGFR-2/Flk-1 kinase
receptor (Schanzer et al. 2004). Thus, both intrinsic and
extrinsic modulation mechanisms are likely in play in
neurogenic niches. Drugs such as simvastatin upregulate
VEGF in DG, stimulate neurogenesis, and enhance
recovery of spatial learning (Morris water maze) in rats
(Wu et al. 2008). A relatively low-dose infusion of VEGF
(2.4 ng/day) into a lateral ventricle (to minimize angio-
genesis and enhanced vascular permeability) resulted in
TBI and choroid plexus–CSF 127
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This intimates a survival-promoting effect by VEGF on
neural progenitors (Schanzer et al. 2004). Strong expres-
sion of VEGFR-2 was observed in the ventricular wall near
CP, a site of signiﬁcant VEGF production. As discussed
above for modulatory neuropeptide sources, for VEGF,
levels 1 (stem cell intrinsic) and 2 (endogenous CSF
extrinsic) are evidently operative in the niche. This gives
rise to possible level 3 (pharmacologic extrinsic) boosting
of CSF VEGF to enhance neurogenesis in treating TBI.
However, a potential therapeutic caveat is offered. One
must consider possible effects of VEGF/nitric oxide in
augmenting CP permeability, already high early in exper-
imental TBI (Sharma et al. 2010) and ischemia (Palm et al.
1995; Sivakumar et al. 2008). Excessive VEGF could place
CSF at risk for destabilization by causing hemorrhaging
through BCSFB.
Nerve growth factor (NGF) compensatory alteration in
brain and CSF, following TBI, has received intense
experimental scrutiny. In reaction to CNS trauma, hippo-
campal NGF upregulates rapidly and displays a biphasic
response (DeKosky et al. 2004). Thus, NGF protein was
increased at 6 h, then declined by 7 days, but then under-
went a second rise at 14 days in rats injured by cortical
impact. Changes in brain NGF upregulation after TBI in
children are reﬂected in CSF levels, which also become
elevated (Chiaretti et al. 2008). NGF upregulation in hip-
pocampus and NGF delivery to CSF (Table 2), after TBI,
helps to reverse cholinergic deﬁcits (acetycholine and
choline acetyl transferase) and restore spatial memory
(Dixon et al. 1997). Evidence that immune system activity
is linked to brain NGF regulation comes from observing
that intraventricularly infused interleukin-1 beta, which is
elevated after trauma, increases NGF in rat cortex and
hippocampus by 2- to 4-fold (DeKosky et al. 1994).
Upregulated NGF has a primary role in restoring cholin-
ergic neurotransmission and related cognition in subjects
compromised by neural trauma.
Epidermal growth factor (EGF) is a commonly used
mitogen for inducing neurogenesis in animal models. EGF,
like FGF2, is involved with cholinergic lineage. EGF is
sometimes combined with other factors (e.g. NGF) in CSF
infusion models to accelerate proliferation of dividing cells
in SVZ of both lesioned and non-lesioned animals (Calza
et al. 2003). EGF and FGF2, combined in intraventricular
infusion, increase post-ischemic neural progenitor cells in
adult rat SVZ and hippocampal DG (Tureyen et al. 2005).
In TBI modeling (Table 2), the infusion of EGF by osmotic
pump into a lateral ventricle for 1 week increased the
number of dividing cells (BrdU?) in hippocampus (Sun
et al. 2010). However, the EGF-induced neurogenesis was
not productive, as manifested by lack of a sustained
increase of BrdU? cells at 4 week after trauma. Still, the
improved cognition in rats at 1 month post-TBI, in spite of
gliosis, was attributed to a neuroprotective rather than
neurogenic effect of EGF.
Glial derived neurotrophic factor (GDNF) exerts neu-
roprotective effects against cerebral ischemia (Lee et al.
2010). GDNF, administered by injection into lateral ven-
tricle CSF, also confers protection in a 4-h whole body
hyperthermia model (Sharma and Johanson 2007b).
Improvement by GDNF treatment in the face of acute
hyperthermia stress is attributable in part to stabilization
(restoration of restricted permeability) of the BBB and
BCSFB; consequently, the CSF and brain extracellular
milieus are less disrupted. This improved neural microen-
vironment, due to tighter barriers, improves cognition and
enables better motor performance on a battery of behav-
ioral tests (Sharma and Johanson 2007b). In a cortical
impact study in rats, GDNF also provided neuroprotection
when administered by osmotic pump into CSF; the hip-
pocampal CA2 and CA3 regions were spared neuronal loss
(Table 2). Another neurotrophin is brain derived neuro-
trophic factor (BDNF). Although not neurogenic (Galvao
et al. 2008), BDNF is neuroprotective in ischemia and
hyperthermia challenges to brain when delivered to CNS
via CSF (Sharma and Johanson 2007b).
Pituitary adenylate cylcase activating polypeptide (PA-
CAP) effectively protects the brain against edema (Naka-
machi et al. 2010), neuronal apoptosis, and the oxidative
stress of hypoxia/ischemia (Stumm et al. 2007). PACAP has
also been tested in TBI modeling (Table 2). Post-injury
administration of PACAP into CSF reduces traumatically
induced axonal injury in rats (Tamas et al. 2006). Immu-
nostaining analyses of damaged axons revealed that PA-
CAP given i.c.v. signiﬁcantly protected the corticospinal
tract in regard to axoplasmic transport and cytoskeletal
integrity (Kovesdi et al. 2008). PACAP may be neuropro-
tective in TFI/TBI through its stimulation of IL-6 secretion
into CSF (Shioda et al. 2004). Il-6 has diverse roles in
minimizing the adverse effects of ischemia and trauma, and
in stimulating neuronal growth. Clearly, yet to be explored
and characterized are many CSF neuroendocrine–immune
system interactions that promote recovery from TBI.
Vistas for CSF translational research in TBI
Exciting prospects are on the horizon, in regard to how CSF
manipulations post-trauma can expedite recovery from the
pathologic sequelae of TBI. More information is needed,
obtained within the same experiment, on how both the
BCSFB and BBB breakdowns in TBI affect the extracel-
lular (interstitial) ﬂuid microenvironment of neuronal net-
works. During the course of TBI and its pathophysiologic
sequelae, there are marked changes in the ﬂuid dynamics
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123(including the distorting effects of cerebral edema) of both
the brain ISF and ventricular CSF with which it functionally
interacts. Because the BCSFB interface controls CSF
dynamics, and the BBB capillaries regulate ISF turnover, it
is of great importance to assess in a given animal the effects
of simultaneous breakdown of both major barrier systems
and the respective ﬂuids regulated by them (Sharma and
Johanson 2007a). Neurogenic regions surrounding the
ventricles are particularly vulnerable. They are modulated
and doubly injured in TBI as the result of the malfunc-
tioning CP (indirectly) and periventricular capillaries
(directly) (Sharma et al. 2006). On the other hand, there is
opportunity for concurrent pharmacologic resolution of
damaged neurogenic niches by delivering therapeutic
agents from both the CSF (CP) and plasma (brain capil-
laries) sides of the SVZ as well as DG. Overall, TBI is a
cogent research/therapeutic challenge (physiologically,
pathologically and pharmacologically)for application to the
complex systems biology approach.
Another investigational requirement is to characterize
more thoroughly the CSF composition of neuropeptides,
proteins, and hormones as a function of TBI stage and
severity; in animals as well as humans. Changes in CSF
peptide levels after TBI induction, for example IGF-1
(Walter et al. 1999) and NGF (Chiaretti et al. 2008), pro-
vide insight on natural homeostatic peptide systems (per-
haps servomechanistic) that can guide the development of
therapeutic strategies and clinical trials. Alterations in CSF
titers of peptides reﬂect cellular actions/events occurring in
both CP and astrocytes. It is important to distinguish
between these two (and other) cellular compartments so
that pharmacological targets can be pinpointed.
Therapeutic targets in the traumatized CNS are diverse.
They include glia, neurons, and endothelium. Why not also
include CP epithelium as a potential target for facilitating
the recovery from TBI-generated damage, or at least pre-
venting a greater degree of injury? As the master homeo-
static organ in CNS, the CP needs protection from
oxidative damage and the noxious substrates that it clears
from CSF. Neurotrophic factors secreted by CP modulate
distant targets via neuroendocrine CSF bulk ﬂow, and
likely also stimulate peptide receptors at the BCSFB by
autocrine/paracrine mechanisms. Because CP capillaries
are not diffusion-restricting (Johanson et al. 2011), like
those at the BBB, a given potentially therapeutic water-
soluble agent is readily accessible to epithelial parenchyma
of CP from the blood side. This favorable accessibility
factor, pharmacokinetically, is expected to increase the
number of drug candidates for protecting the BCSFB.
It is now evident that many different peptides in CSF
bestow neuroprotective and neuroregenerative effects on
brain parenchyma and the cells bordering the ventricles. In
the natural setting, this endogenous battery of CSF-borne
peptides confers a wide spectrum of beneﬁts to the CNS.
The basis for this phenomenon is largely the normal CP
secretion of a plethora of growth factors and neurotrophins
into CSF that are increased in response to ischemia, TBI,
and other neurodegeneration. This physiologic reality
prompts the consideration that a pharmacologic mixture, or
cocktail, of growth factors and neurotrophins (Sharma et al.
2010) would exogenously provide additive or synergistic
effects on neurogenesis, angiogenesis, and neuroprotection.
Some animal model approaches have already used this
strategy (Tureyen et al. 2005). More experimental infor-
mation is desirable to evaluate the effects of neuropeptide
cocktails,inthecontextofexogenousCSFsupplementation,
in neurodegeneration models such as ischemia and TBI.
Promising data have been obtained from animal
research, in regard to favorable effects of a wide variety of
CSF-delivered neuropeptides to boost CNS function in
repair states. Caveats are necessary, however, for the pos-
sibility that too much of a dose, or the inappropriate
combination, of growth factors could predispose toward
oncogenicity or aberrant incorporation of new neurons into
circuitry (leading to seizures). Future research can sort out
and eliminate unfavorable side effects by selecting the best
protocols for CSF neuropeptide supplementation in TBI
treatment. Upon procuring TBI recovery data for animals
that consistently point to safe/effective regimens for CSF
peptide manipulations, there will be numerous venues for
expanding translational research: CP transplants (Borlon-
gan et al. 2004; Emerich et al. 2005), the use of capsules or
beads (intraventricular or intraparenchymal instillation) to
encase cells bioengineered to secrete certain neuropeptides
(Heile et al. 2009), cisternal injection of marrow stromal
cells (Hu et al. 2005), and perhaps eventually the trans-
genetic/vector manipulation of CP/BCSFB (Gonzalez et al.
2010; Regev et al. 2010) to control more ﬁnely neuro-
peptide secretion into CSF for the brain’s beneﬁt.
Conclusion
Functional destabilization of the choroid plexuses and
ependymal wall in the brain interior following TBI has
marked effects on CSF homeostasis and periventricular
neurogenic niche viability. Pharmacologic boosting of the
impaired ventricular CSF system with appropriate growth
factors/neurotrophins may improve neurogenesis and help
restore cognitive abilities diminished by neural trauma.
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